DS
EOLS icon

David Shaw’s Evolus EOLS Stock Holding History

David Shaw’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-50,000
Closed -$595K – 3678
2018
Q4 		$595K Buy
+50,000
New +$713K ﹤0.01% 2996

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

David Shaw's EOLS Position: Q2 2026 in Review

David Shaw reduced its Evolus (EOLS) stake by 40% in Q2 2026, selling an estimated $1.31M and leaving 336,901 shares worth $2.34M. The position accounts for ﹤0.01% of the portfolio, ranked #3069.

David Shaw first reported a position in EOLS in Q3 2018 and has held it in 23 quarters since. The position peaked at $15.7M in Q3 2024. 158 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • David Shaw held 336,901 shares of Evolus worth $2.34M as of Q2 2026.
  • David Shaw sold 222,149 Evolus shares in Q2 2026, an estimated $1.31M.
  • Evolus made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #3069 holding.
  • David Shaw first reported a position in Evolus in Q3 2018 and has held it in 23 quarters since.
  • David Shaw's Evolus position peaked at $15.7M in Q3 2024.
  • 158 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.